Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)

Name: Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)
Published: 2013
License: Public Domain

Boehringer Ingelheim · 2013

ClinicalTrials.gov · Datasets · License: Public Domain · 2013

Open Source ↗

acute leukemia myeloid

leukemia, myeloid, acute, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)

Related documents